Aims and Scope
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of cutting-edge research from global biomedical researchers across the cancer sciences. The journal considers submissions from all oncologic specialties, including, but not limited to, the following areas
Cancer biology
Molecular biology o cellular biology o molecular genetics o genomics o immunology o epigenetics o metabolic studies o proteomics o cytopathology o carcinogenesis o drug discovery and delivery
Clinical cancer research
Translational research o clinical trials o chemotherapy o radiation therapy o surgical therapy o clinical observations o clinical guidelines o genetic consultation o ethical considerations
Cancer prevention
Behavioral science o psychosocial studies o screening o nutrition o epidemiology and prevention o community outreach
Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
We aim to be a truly global forum for high-quality cancer research, and we think that the best research should be published and made widely accessible as quickly as possible. Cancer Medicine publishes papers submitted directly to the journal and those referred from a select group of prestigious journals published by Wiley-Blackwell.
Cancer Medicine is a Wiley Open Access journal, one of a new series of peer-reviewed titles publishing quality research with speed and efficiency. For further information visit the Wiley Open Access website at http://www.wileyopenaccess.com.
Open Access and Copyright
All articles published by Cancer Medicine are fully open access: immediately freely available to read, download and share. All articles accepted from 14 August 2012 are published under the terms of the Creative Commons Attribution License. All articles accepted before this date were published under a Creative Commons Attribution Non-Commercial License. The Creative Commons Attribution License permits use, distribution and reproduction in any medium, provided the original work is properly cited and allows the commercial use of published articles. Copyright on any research article in a journal published by Cancer Medicine is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Further information about open access license and copyright can be found at http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html
Purchasing Print Reprints
Print reprints of Wiley Open Access articles can be purchased from corporatesales@wiley.com.
Disclaimer
The Publisher and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily refl ect those of the Publisher and Editors, neither does the publication of advertisements constitute any endorsements by the Publisher and Editors of the products advertised.
Wiley Open Access articles posted to repositories or websites are without warranty from Wiley of any kind, either express or implied, including, but not limited to, warranties of merchantability, fi tness for a particular purpose, or non-infringement. To the fullest extent permitted by law Wiley disclaims all liability for any loss or damage arising out of, or in connection with, the use of or inability to use the content.
Editor-in-Chief
Qingyi Wei, M.D., Ph.D. The University of Texas MD Anderson Cancer Center, Houston, USA
Editorial Board
Cancer Biology
Richard J. Ablin University of Arizona College of Medicine, Tucson, USA
Rosalind Eeles Institute of Cancer Research, Sutton, UK
Elizabeth A. Grimm The University of Texas MD Anderson Cancer Center, Houston, USA
Giseli Klassen Federal University of Parana, Curitiba, Brazil
Gang Li University of British Columbia, Vancouver, Canada
Youyong Lu Beijing Institute for Cancer Research, Beijing, China
Kenneth Offit Memorial Sloan-Kettering Cancer Center, New York, USA
Athanasios G. Papavassiliou University of Athens Medical School, Athens, Greece
Kenneth Pienta University of Michigan, An Arbor, USA
Jack A. Schalken Radboud University Medical Centre, Nijmegen, Netherlands
Kazu Ushijima National Cancer Center, Tokyo, Japan
David Vaux Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
Cun-Yu Wang UCLA School of Dentistry, Los Angeles, USA
Hongyang Wang Eastern Hepatobiliary Surgery Institute / Hospital, Shanghai, China
Momiao Xiong The University of Texas Health Science Center, Houston, USA
Li Zhang The University of Texas MD Anderson Cancer Center, Houston, USA
Clinical Cancer Research
Yung-Jue Bang Seoul National University College of Medicine, Seoul, Korea
Anthony Chan The Chinese University of Hong Kong, China
Jiuwei Cui The First Hospital of Jilin University, Jilin, China
Peter J. Fuller Prince Henry Institute, Victoria, Australia
Maura L. Gillison Ohio State University Comprehensive Cancer Center, Columbus, USA
Guido Kroemer University of Paris Descartes, Paris, France
Lalit Kumar All India Institute of Medical Sciences, New Delhi, India
Razelle Kurzrock The University of Texas MD Anderson Cancer Center, Houston, USA
Geoffrey Liu Princess Margaret Hospital, Toronto, Canada
Jiade J. Lu National University of Singapore, Singapore
Li Mao University of Maryland, Baltimore, USA
Akira Nakagawara Chiba University, Chiba, Japan
Pamela L. Paris University of California, San Francisco, USA
Dimitrios H. Roukos Ioannina University School of Medicine, Ioannina, Greece
Frank A. Sinicrope Mayo clinic, Rochester, USA
Jun Wang BGI-Shenzhen, Shenzhen, China
Glen J. Weiss Translational Genomics Research Institute, Phoenix, USA
Senming Wang Southern Medical University, Guangzhou, China
Eric T. Wong Beth Israel Deaconess Medical Center, Boston, USA
Xianglin Yuan Huazhong University of Science and Technology, Wuhan, China
Cancer Prevention
Marianne Berwick University of New Mexico, Albuquerque, USA
Paolo Boffetta The Tisch Cancer Institute, New York, USA
Eduardo Cazap Latin-American & Caribbean Society of Medical Oncology, Buenos Aires, Argentina
Brock C. Christensen Dartmouth Medical School, Hanover, USA
Steve Dubinett David Geffen School of Medicine at UCLA, Los Angeles, USA
Kari Hemminki German Cancer Research Center, Heidelberg, Germany
Zhibin Hu Nanjing Medical University, Nanjing, China
Stephen D. Hursting The University of Texas, Austin, USA
Daehee Kang Seoul National University College of Medicine, Seoul, Republic of Korea
Lambertus A. Kiemeney Radboud University Medical Centre, Nijmegen, Netherlands
Donghui Li The University of Texas MD Anderson Cancer Center, Houston, USA
Dongxin Lin Chinese Academy of Medical Sciences, Beijing, China
Somdat Mahabir National Cancer Institute, Bethesda, USA
Girish Maru ACTREC Tata Memorial Centre, Navi Mumbai, India
Andrew Olshan University of North Carolina, Chapel Hill, USA
Jong Y. Park H. Lee Moffi tt Cancer Center & Research Institute, Tampa, USA
Susan K. Peterson The University of Texas MD Anderson Cancer Center, Houston, USA
Thomas E. Rohan Albert Einstein College of Medicine, Bronx, USA
Xifeng Wu The University of Texas MD Anderson Cancer Center, Houston, USA
Editorial Advisory Board
Lawrence Baker University of Michigan, Ann Arbor, USA
David Christiani Harvard School of Public Health, Boston, USA
Robert B. Diasio Mayo Clinic, Rochester, USA
B. Mark Evers Lucille P. Markey Cancer Center, Lexington, USA
Waun Ki Hong The Univeristy of Texas MD Anderson Cancer Center, Houston, USA
Ernest Hawk The University of Texas MD Anderson Cancer Center, Houston, USA
Leroy Hood Institute for Systems Biology, Seattle, USA
James Mulé H. Lee Moffi tt Cancer Center & Research Institute, Tampa, USA
Philip Agop Philip Wayne State University, Detroit, USA
Nicholas Vogelzang Comprehensive Cancer Centers of Nevada, Vegas, USA